Top | Features
(article, Rebecca Kessler)
[%pageBreakSettings maxWords=1000] Trout with double the usual amount of muscle, pork loaded with omega-3 fatty acids, and beef from cattle resistant to mad-cow disease are just a few products from genetically engineered animals under development in labs around the world. Now that GE plant products appear in some three-fourths of the processed food in a typical U.S. grocery store, it’s only a matter of time before GE animal products hit the fridge shelves, too. In fact, a Massachusetts company, AquaBounty Techologies, announced last month that it expects a green light from the Food and Drug Administration "in the near future." Its product, the AquAdvantage® salmon, is an Atlantic salmon with introduced genes from two other fish species that make it grow to marketable size twice as fast as ordinary Atlantic salmon. If it’s approved, it will probably be the first GE animal out of the gates. [%image reference-image float=right width=400 caption="This chicken has not been genetically engineered by scientists."]A little over a year ago, the FDA issued its final guidance on genetically engineered animals, laying out the process GE animals will have to go through before they can be brought to market. The agency says developers must show that the introduced genetic material is safe for the animals, human consumers, and the environment. So, all things considered, how long before we find GE meat on our plates? h3. GE animals today First of all, to be crystal clear, no GE animals have been approved for human consumption, and the FDA says it is not aware of any that might have circumvented its review process and gone straight to market. The majority of GE animals under development are for so-called biopharm purposes, not straight-up eating. The only animal the FDA has approved so far is a goat engineered to produce a protein in its milk that’s used in a drug for people with a blood-clotting disorder. Also available commercially are GE lab rats and mice used in research, which do not require formal FDA approval, and GloFish®, an aquarium fish that fluoresces thanks to spliced-in coral DNA. The GloFish snuck onto the market in 2003 and the agency quickly exempted it from the need for a review, contending it poses a negligible risk to the environment, and isn’t intended to be eaten. Despite the pass given the lab rats and aquarium fish, the FDA’s website states that it “expects to require approval of all GE animals intended to go into the human food supply.” Agency spokesperson Siobhan DeLancey said via email that “Enforcement action may include criminal penalties.” Controversially, the FDA is regulating GE animals the same way it regulates new drugs for nonhuman animals. It’s the introduced DNA — not the animals themselves — that the agency considers a drug. As with drugs, protection of intellectual property is a top priority, and the FDA cannot disclose which animals have been submitted for review, how far along they are, or even how many are in the approval pipeline. While the agency says it intends to invite the public to attend meetings and offer comments prior to approving a GE animal, it's committed to protecting corporate trade secrets, so it may withhold some of the data used to evaluate safety. That lack of transparency has raised serious concerns. So far, only two developers have made their applications public — though it appears likely that there are other applications in the works. Experts say one of the two will probably be the first to market, and right now that looks to be AquaBounty, developer of the fast-growing AquAdvantage® Salmon. The company says it began its attempt to gain the FDA’s approval for the fish more than a decade ago, and now believes the process is nearly complete. The FDA’s DeLancey confirms that public meetings may take place this fall, at the earliest. Still, AquaBounty says it will likely take another two to three years after approval for the fish to appear in grocery stores, according to the New York Times, which notes that the company has made “overly optimistic” predictions in the past. The other known contender is Enviropig™, created by researchers at the University of Guelph in Ontario by inserting mouse and E. coli genes into an ordinary Yorkshire pig’s genome. The pig produces an enzyme that lets it break down phosphorous in plant matter. As a result, it requires fewer nutritional supplements and poops out waste that's less polluting. In February, the Canadian government cleared Enviropigs for research production, a big step forward. Researchers submitted their Enviropigs to the FDA in 2007 but won’t publicly predict when they might be approved. “I’m going to be surprised if it takes longer than five years” for either the salmon or the pig to make it to market, says Kevin Wells, an animal biotechnologist at the University of Missouri, who has been involved in GE-animal research for over a decade. What comes next depends on the public’s reaction. If it’s positive or neutral, Wells expects many more GE critters will follow — after a certain time lag while they wend their way through the FDA’s review process. Being first may have its disadvantages, says Wells. "Because the first person to bring something to market will have to deal with the public perceptions.” h3. The creep factor Indeed, it’s hard to imagine a more contentious consumer topic than GE food. The concerns about GE animals are familiar from the battles over GE plants. Critics cite studies indicating possible adverse health effects from GE plants common in the food supply, and wonder whether GE animals will turn out to be the same. They worry about farming economics, and the environmental consequences should GE organisms escape cultivation and interbreed with their wild relatives. They are openly distrustful of researchers, the corporations that fund research, and the FDA. And they dismiss many of the touted benefits of GE animal foods: better nutritional characteristics, faster growth on less feed, reduced environmental footprints, and disease resistance. “There’s no good reason to do it,” says Ronnie Cummins, the director of the Organic Consumers Association, which opposes all genetically modified organisms. “Does it increase the quantity of food? No. Does it make crops use less pesticides? No. Does it make animals healthier, happier? No.” For people like Cummins, it’s the agricultural system, not the animals trapped in it, that needs to change: “Designing animals so they can live under hellish factory-farm conditions is not anything the public will ever go along with. It’s an industry-driven thing. The public wants an end to factory farms, period,” says Cummins. One of the most eye-popping suggestions along those lines came in a February 19 New York Times op-ed that suggested engineering livestock to have a dulled sense of pain so the animals could comfortably withstand the tribulations of factory farming. h3. A labelous claim Perhaps the provision of the FDA’s guidance that raises hackles the most is that, as with plants, there is no requirement that all GE animal products be labeled. In addition to allowing those who want to avoid GE products for whatever reason to do so, Cummins and others argue that labeling is essential so any harmful effects that might emerge can be identified and studied down the line. “A policy that doesn’t require labeling undermines the confidence in the technology. It looks like they’ve got something to hide,” says Margaret Mellon, the director of the food and environment program for the Union of Concerned Scientists. The group is skeptical about the value of genetically engineering plants and animals in the food supply, while supporting the technology’s use in research and drug production. “I know the arguments against it, that somehow if you label it as engineered, people are going to assume something’s wrong with it. But I think consumers are smarter than that. There is no reason to deprive people of choice.” [%image piglets float=right width=300 caption="Piglets at play."]That said, she points out that whereas there is some credible science suggesting adverse health affects from certain GE plants, GE animals are unlikely to prove harmful. “Animals tend not to produce a whole lot of toxic substances,” she says, “so it’s unlikely that you would be turning on silent genes, or increasing levels of toxins in genetically engineered animals.” But the labeling point may be moot with GE animals, both Mellon and Wells, the GE animal researcher, agree. Developers will most likely want to brag about their products, rather than sneak them quietly into the food supply. “Any transgenic animal product that comes to market will only succeed if people want it because it’s transgenic,” says Wells. “I think the companies are going to want to advertise it as such.” Expect labels trumpeting “Salmonella-free chicken” or “Genetically enhanced for your safety,” he says. h3. The transgene promise Wells says there's a lot of public misunderstanding out there about his field. Contrary to popular belief, he says, money for research into GE animals is actually limited, with public agencies and corporations alike shying away from funding the work for fear of a public backlash. He chalks much of the public opposition to GE animals up to a fear of the unknown, pointing out that people already regularly ingest many of the genes being swapped between organisms. He points out that tomatoes and celery both belong to plant families with poisonous members, but there’s no limit whatsoever on the kind of traditional plant crossing researchers can do with those species, even though the resulting vegetables could turn out to be noxious. Fundamentally, he expects GE animals to be safe to eat because at the end of the day, the animals themselves have to be healthy. Ultimately, believers in the promise of genetic engineering think the societal benefits will far outweigh any risk. “I see lots of problems that I don’t know any other way to solve other than through genetic engineering,” says Wells — chief among them being food-safety issues. He notes that it would be relatively simple to engineer a cow that would produce beef no E. coli_ could grow in. He also sees great potential to reduce the food, supplement, and drug inputs and the harmfulness of the waste outputs of modern animal agriculture. At a conference in San Diego in February at which a Monsanto representative spoke, a lively protest by several dozen anti-genetic-engineering activists broke out. Wells said he waded into the fray, and after being shouted at and called names like “cow-raper,” “vivisectionist,” and “murderer,” spent an hour speaking with the protesters. He doesn’t think he changed any minds, but hopes he might have opened some. The discussion will only get louder as we draw nearer to the moment when the first GE animal is served up for dinner. The only thing nobody seems to be talking about? How it will taste. p(bio). Rebecca Kessler writes about science, the environment, and food. She lives in Providence, Rhode Island.